Supplement × Prescription·a caution·Moderate evidence

Alpha-Lipoic Acid + Tirzepatide

Caution Moderate evidence

Alpha-lipoic acid may improve insulin sensitivity and lower glucose, which can add to tirzepatide's glucose-lowering effects.

From the database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, and the recommendation.

Pair type
Caution
Evidence
Moderate
Source citations
3
Scope
Supplement × Prescription
Last verified
June 1, 2026
CautionModerate evidence

What is happening. Alpha-lipoic acid may improve insulin sensitivity and lower glucose, which can add to tirzepatide's glucose-lowering effects.

Mechanism. Alpha-lipoic acid can affect insulin signaling and glucose uptake. Tirzepatide improves glucose-dependent insulin secretion and lowers glucagon through incretin receptor activation.

Recommendation. Use caution when combining alpha-lipoic acid with tirzepatide. Monitor blood glucose more often when starting or changing alpha-lipoic acid, especially if also taking insulin or sulfonylureas.

Stack Score

How it moves the number.

Effect on the composite score

If both Alpha-Lipoic Acid and Tirzepatide are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.

Sources

Sources, by evidence tier.

Every claim on this page is cited. PMIDs link straight to PubMed.

Check your full routine

One pair was the worked example.

Drop your supplements and prescriptions into NutriStack and it runs every pair at once: every interaction, synergy, timing rule, and contraindication, each linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.